Market Overview

Stocks Hitting 52-Week Lows

Related HTS
UPDATE: Bank of America Reiterates on Hatteras Financial Following Good Q4 '13 Results
UPDATE: Compass Point Upgrades Hatteras Financial Corp. Following 3Q13 Earnings Report
Related MYGN
Edwards Lifesciences Raised to Buy - Analyst Blog
ImmunoGen, Inc. (IMGN) in Focus: Stock Rallies 11% - Tale of the Tape

Hatteras Financial (NYSE: HTS) shares reached a new 52-week low of $16.173. Hatteras Financial's trailing-twelve-month profit margin is -6.57%.

Myriad Genetics (NASDAQ: MYGN) shares touched a new 52-week low of $20.14. Myriad Genetics expressed concerns over CMS not valuing BRCA 2 gene in 81211 code, CMS 81211 payment rate. Mizuho Securities downgraded the stock from Buy to Neutral.

Gyrodyne Co. of America (NASDAQ: GYRO) shares touched a new 52-week low of $67.52. Gyrodyne Co. of America shares have dropped 4.52% over the past 52 weeks, while the S&P 500 index has gained 29.11% in the same period.

Can-Fite BioPharma (NYSE: CANF) shares reached a new 52-week low of $5.551 after the company's subsidiary OphthaliX (OTC: OPLI) reported that its phase III study with its licensed drug CF101 for moderate-to-severe dry eye syndrome did not meet primary efficacy endpoint.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets


Most Popular

Related Articles (GYRO + CANF)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free